期刊文献+

Interventional treatment for congenital heart disease and its severe complications

Interventional treatment for congenital heart disease and its severe complications
原文传递
导出
摘要 Background To approach the incidence, cause and possible treatment of severe complications induced during or after congenital heart disease interventions. Methods Interventional procedures of congenital heart disease were performed in 654 patients from January 2003 to October 2009, which were divided into four groups, i.e. patent ductus arteriosus (PDA), atrial septum defect (ASD), pulmonary stenosis(PS), ventricular septum defect(VSD), among them 32 patients with severe complications were retrospectively analyzed. Results A total of 654 cases accepted the treatment of intrusion. There was one death in all the patients, ten patients failed in the operation. The overall severe complication rate was 4.89% (32/654), in which 2.29%(4/175) in PDA group, 5.26%(10/190) in ASD group, 5.77% (3/52) in PS group, 6.33%(15/237) in VSD group, respectively. Conclusions The severe complication rates of interventional therapy for congenital heart disease are low, it is a relatively safe interventional method, and careful supervision is necessary during or after procedure. Background To approach the incidence, cause and possible treatment of severe complications induced during or after congenital heart disease interventions. Methods Interventional procedures of congenital heart disease were performed in 654 patients from January 2003 to October 2009, which were divided into four groups, i.e. patent ductus arteriosus (PDA), atrial septum defect (ASD), pulmonary stenosis(PS), ventricular septum defect(VSD), among them 32 patients with severe complications were retrospectively analyzed. Results A total of 654 cases accepted the treatment of intrusion. There was one death in all the patients, ten patients failed in the operation. The overall severe complication rate was 4.89% (32/654), in which 2.29%(4/175) in PDA group, 5.26%(10/190) in ASD group, 5.77% (3/52) in PS group, 6.33%(15/237) in VSD group, respectively. Conclusions The severe complication rates of interventional therapy for congenital heart disease are low, it is a relatively safe interventional method, and careful supervision is necessary during or after procedure.
出处 《South China Journal of Cardiology》 CAS 2010年第1期28-33,共6页 岭南心血管病杂志(英文版)
基金 supported by the grants from the Natural Science Foundation of Anhui Province (No.090413269X) the Youth Research Program of Anhui Provincial Health Department (No.09B106)
关键词 congenital heart disease COMPLICATIONS interventional therapy congenital heart disease complications interventional therapy
  • 相关文献

参考文献13

  • 1CHEN Zhao-yang WU Li-ming LUO Yu-kun LIN Chao-gui PENG Ya-fei ZHEN Xing-chun CHEN Liang-long.Comparison of long-term clinical outcome between transcatheter Amplatzer occlusion and surgical closure of isolated patent ductus arteriosus[J].Chinese Medical Journal,2009(10):1123-1127. 被引量:10
  • 2Jiang Shi-Liang,Xu Zhongying,Huanglian Army, et al.Using Amplatzer duct occluder treatment of secundum atrial septal de- fect prevention of complications. Chinese Journal of Intervention- al Cardiology . 2004
  • 3Wang Yi.Interventional treatment of congenital heart disease and treatment of common complications. Practical Clinical Journal of Pediatrics . 2005
  • 4Editorial Board of Chinese Journal of Pediatrics,Chinese Medical Journal Editorial Board.Transcatheter interventional therapy of congenital heart disease guidelines. China Pediatrics . 2004
  • 5Holzer R,Balzer D,Cao QL,et al.Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a US registry. Journal of the American College of Cardiology . 2004
  • 6Pesenti-Rossi D,Godart F,Dubar A,et al.Transcatheter closure of traumatic ventricular septal defect:an alternative to surgery. Chest . 2003
  • 7Du,Z,Hijazi,Z,Kleinman,C.Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults. Journal of the American College of Cardiology . 2002
  • 8Aiqin Zhou.The present amd future of intervention catheterization for congenital heart disease. Chinese Medical Journal . 2001
  • 9Chessa M,Carminati M,Butera G,et al.Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. Journal of the American College of Cardiology . 2002
  • 10Bergs F,Ewent P,Abdul K,et al.Percutaneous closure of large atrial defects with the Amplatzer septal occluder. Journal of Interventional Cardiology . 2001

二级参考文献19

  • 1Schneider DJ,Moore JW.Patent ductus arteriosus.Circulation 2006; 114:1873-1882.
  • 2Mavroudis C,Backer CL,Gevitz M.Forty-six years of patent ductus arteriosus division at Children's Memorial Hospital of Chicago.Standards for comparison.Ann Surg 1994; 220:402-409.
  • 3Masura J,Tittle P,Gavora P,Podnar T.Long-term outcome of wanscatheter patent ductus arteriosus closure using Amplatzer duct occluders.Am Heart J 2006; 151:755.
  • 4Pass RH,Hijazi Z,Hsu DF,Lewis V,Hellenbrand WE.Mulficenter USA Amplatzer patent ductus arteriosus occlusion device trial.Initial and one-year results.J Am Coil Cardiol 2004; 44:513-519.
  • 5Hawkins JA,Minich LL,Tani LY,Stortevant JE,Orsmond GS,McGough EC.Cost and efficacy of surgical ligation versus transcatheter coil occlusion of patent ductus arteriosus.J Thorac Cardiovasc Surg 1996; 112:1634-1638.
  • 6National Institute for Clinical Excellence.Interventional procedure consultation document-endovascular closure of patent ductus arteriosus.(Accessed October 20,2004 at www.nice.org.uk).
  • 7Godart ERodes J,Rey C.Severe haemolysis after transcatheter closure of a patent arterial duct with the new Amplatzer duct occluder.Cardiol Young 2000; 10:265-267.
  • 8McMullan DM,Moulick A,Jonas RA.Late embolization of Amplatzer patent ductus arteriosus occlusion device with thoracic aorta embedment.Ann Thorac Surg 2007; 83:1177-1179.
  • 9Prieto LR,DeCamilio DM,Konrad D J,Scalet-Longworth L,Latson LA.Comparison of cost and clinical outcome between transcatheter coil occlusion and surgical closure of isolated patent ductus arteriosus.Pediatrics 1998; 101:1020-1024.
  • 10Gray DT,Fyler DC,Walker AM,Weinstein MC,Chalmers TC.Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus.N Engl J Meal 1993; 329:1517-1523.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部